Consolidative thoracic radiotherapy for extensive stage small cell lung cancer

Extensive stage small cell lung cancer (ES-SCLC) represents approximately half of all diagnosed small cell lung cancer worldwide. It is notorious for a high risk of local recurrence although it’s sensitive to chemotherapy. Nearly 90% of intrathoracic failures happen in the first year after diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoli, Yu, Jinming, Zhu, Hui, Meng, Xue, LI, Minghuan, Jiang, Liyang, Ding, Xingchen, Sun, Xindong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400661/
https://www.ncbi.nlm.nih.gov/pubmed/28118612
http://dx.doi.org/10.18632/oncotarget.14759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400661/
https://www.ncbi.nlm.nih.gov/pubmed/28118612
http://dx.doi.org/10.18632/oncotarget.14759

Ejemplares similares